E0671 + rabeprazole sodium + E0671 placebo
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Stomach Ulcer
Conditions
Stomach Ulcer
Trial Timeline
Aug 1, 2005 → Apr 19, 2007
NCT ID
NCT00125736About E0671 + rabeprazole sodium + E0671 placebo
E0671 + rabeprazole sodium + E0671 placebo is a approved stage product being developed by Eisai for Stomach Ulcer. The current trial status is completed. This product is registered under clinical trial identifier NCT00125736. Target conditions include Stomach Ulcer.
What happened to similar drugs?
0 of 7 similar drugs in Stomach Ulcer were approved
Approved (0) Terminated (1) Active (6)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00125736 | Approved | Completed |
Competing Products
20 competing products in Stomach Ulcer